PureCycle Technologies, Inc. Form 8-K Summary
Business Context and Reporting Period
This Form 8-K reports corporate governance changes effective March 15, 2022. PureCycle Technologies develops ultra-pure recycled resin. The filing is not a quarterly or annual financial report and does not provide operating results for a reporting period.
Key Financial and Operating Information
- The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial statement metrics.
- Operations at the Ironton, Ohio facility were scheduled to begin in the fourth quarter of 2022.
- Estimated 2022 additive purchases under the Milliken supply agreement were approximately $385,000.
- Estimated additive purchases over the remaining term of the agreement, including 2022, were approximately $107.8 million, based on current market conditions and operating forecasts.
Material Changes and Appointments
- Richard Brenner resigned from the Board effective March 15, 2022. The company stated that the resignation was not due to any disagreement with the company or management.
- Allen W. Jacoby was elected as a Class II director and Stephen F. Bouck as a Class III director, both effective March 15, 2022.
- The Board determined that both appointees qualify as independent directors under Nasdaq listing standards.
- Committee assignments had not been determined as of the filing date.
Guidance, Risks, Contingencies, and Unusual Items
- New non-employee directors generally receive an annual restricted stock unit grant targeted at $100,000 in fair market value, annual cash compensation of $65,000, and additional committee-related compensation ranging from $7,500 to $30,000.
- Mr. Jacoby is employed by Milliken & Company, which entered into a 10-year exclusive supply agreement with PureCycle on March 15, 2019.
- The agreement requires Milliken to supply additives for PureCycle’s recycled resin production. Pricing is not fixed and is to be reasonable based on industry conditions, with initial pricing to be negotiated in good faith.
- No payments are due under the agreement until initial production at the Ironton Facility begins.
- Initial pricing and specified quantities had not yet been agreed as of the filing. The company’s cost estimates could change with commodity prices, supply chain conditions, operational efficiencies, production timing, or actual purchase volumes.
- The company specifically cited significant supply chain disruptions and commodity shortages in developing its estimates.
Most Important Facts to Verify
- Whether Ironton Facility operations began as scheduled in the fourth quarter of 2022.
- Actual additive pricing, quantities, and purchases under the Milliken agreement compared with the $385,000 2022 estimate and $107.8 million remaining-term estimate.
- Any subsequent changes to the Board committee assignments or director compensation.
- Whether the Milliken-related arrangement resulted in additional related-party disclosures or changes in contract terms.